SG11201908060PA - Wound healing medicament - Google Patents

Wound healing medicament

Info

Publication number
SG11201908060PA
SG11201908060PA SG11201908060PA SG11201908060PA SG11201908060PA SG 11201908060P A SG11201908060P A SG 11201908060PA SG 11201908060P A SG11201908060P A SG 11201908060PA SG 11201908060P A SG11201908060P A SG 11201908060PA SG 11201908060P A SG11201908060P A SG 11201908060PA
Authority
SG
Singapore
Prior art keywords
international
sheffield
viii
rule
wound healing
Prior art date
Application number
SG11201908060PA
Other languages
English (en)
Inventor
Muhammad Yar
Sheila Macneil
Original Assignee
Univ Sheffield
Comsats Institute Of Information Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sheffield, Comsats Institute Of Information Tech filed Critical Univ Sheffield
Publication of SG11201908060PA publication Critical patent/SG11201908060PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201908060PA 2017-03-07 2018-03-07 Wound healing medicament SG11201908060PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1703656.7A GB201703656D0 (en) 2017-03-07 2017-03-07 Wound healing medicament
PCT/GB2018/050579 WO2018162900A1 (en) 2017-03-07 2018-03-07 Wound healing medicament

Publications (1)

Publication Number Publication Date
SG11201908060PA true SG11201908060PA (en) 2019-09-27

Family

ID=58543858

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908060PA SG11201908060PA (en) 2017-03-07 2018-03-07 Wound healing medicament

Country Status (9)

Country Link
US (3) US20210154206A1 (https=)
EP (2) EP4233911A3 (https=)
JP (3) JP7710206B2 (https=)
CN (1) CN110612106A (https=)
CA (1) CA3055467A1 (https=)
ES (1) ES2955029T3 (https=)
GB (1) GB201703656D0 (https=)
SG (1) SG11201908060PA (https=)
WO (1) WO2018162900A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013106822A1 (en) 2012-01-12 2013-07-18 Johnson Jed K Nanofiber scaffolds for biological structures
GB201703656D0 (en) 2017-03-07 2017-04-19 Univ Sheffield Wound healing medicament
EP3870125A4 (en) * 2018-10-24 2022-08-03 Somnio Global Holdings, LLC FUNCTIONAL WOUND HEALING DRESSINGS
WO2020123619A1 (en) 2018-12-11 2020-06-18 Nanofiber Solutions, Llc Methods of treating chronic wounds using electrospun fibers
WO2022016268A1 (en) * 2020-07-22 2022-01-27 The University Of British Columbia Blended polyvinyl alcohol drug delivery systems
WO2022076117A1 (en) * 2020-09-08 2022-04-14 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds
CN115770322A (zh) * 2022-11-29 2023-03-10 江南大学 一种免疫调节水凝胶及其制备方法和应用
CN115944774A (zh) * 2022-12-04 2023-04-11 吉林大学 一种迷迭香酸-壳聚糖-聚乙烯醇水凝胶敷料及其制备方法和应用
TR2022021580A2 (tr) * 2022-12-30 2023-01-23 S D Ue Idari Ve Maliis Dai Bas Genelsekreterlik Yumurta aki esasli nanoli̇fli̇ tedavi̇ malzemesi̇ geli̇şti̇ri̇lmesi̇
CN116459383B (zh) * 2023-02-28 2024-07-19 兰州大学 一种用于促进糖尿病伤口愈合的铈基mof水凝胶及其制备方法和应用
CN118831037B (zh) * 2024-06-28 2025-02-25 广东适配生物科技有限公司 一种负载微球和纳米酶的多功能微针及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232318B (it) * 1989-09-07 1992-01-28 Crinos Industria Farmaco Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
US5177065A (en) * 1990-12-26 1993-01-05 Silvetti Sr Anthony N Monosaccharide containing wound healing preparation
WO1998046206A1 (en) 1997-04-16 1998-10-22 Peregrine Pharmaceutical, Inc. Skin cream composition
US7090745B2 (en) * 2002-09-13 2006-08-15 University Of Pittsburgh Method for increasing the strength of a cellulosic product
FR2854243A1 (fr) 2003-04-24 2004-10-29 Oreal Procede de determination d'etats pre-alopeciques et/ou d'atteintes cutanees au moyen d'un marqueur predictif: hif-1(hypoxia inducible factor-1)
US8178656B2 (en) * 2004-06-11 2012-05-15 Trustees Of Tufts College Silk-based drug delivery system
FR2879443B1 (fr) * 2004-12-21 2007-07-13 Jean Noel Thorel Utilisation d'une base nutritive complexe dans le domaine cosmetique, en particulier capillaire
JPWO2007129618A1 (ja) 2006-05-08 2009-09-17 国立大学法人 香川大学 好中球の活性化および遊走因子の抑制剤およびその利用
GB0813541D0 (en) * 2008-07-24 2008-08-27 Brightwake Ltd Honey wound dressing
US20110104279A1 (en) * 2009-11-04 2011-05-05 Marraccini Philip A Healing powder and method of use thereof
JP2013521230A (ja) 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法
KR20150007276A (ko) * 2011-10-28 2015-01-20 밸리언트 캐나다 엘피 원형탈모증의 예방 및 치료를 위한 인삼 추출물의 사용
US9610282B2 (en) * 2013-03-12 2017-04-04 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process
GB201703656D0 (en) 2017-03-07 2017-04-19 Univ Sheffield Wound healing medicament

Also Published As

Publication number Publication date
JP2020510701A (ja) 2020-04-09
GB201703656D0 (en) 2017-04-19
US20250099486A1 (en) 2025-03-27
BR112019018596A2 (pt) 2020-04-07
JP2023078307A (ja) 2023-06-06
EP3681509B1 (en) 2023-06-07
US20250025474A1 (en) 2025-01-23
ES2955029T3 (es) 2023-11-28
EP4233911A3 (en) 2023-09-20
EP3681509C0 (en) 2023-06-07
JP7710206B2 (ja) 2025-07-18
CN110612106A (zh) 2019-12-24
JP2025172803A (ja) 2025-11-26
WO2018162900A1 (en) 2018-09-13
CA3055467A1 (en) 2018-09-13
EP3681509A1 (en) 2020-07-22
EP4233911A2 (en) 2023-08-30
US20210154206A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
SG11201908060PA (en) Wound healing medicament
SG11201908567UA (en) Modified cyclic dinucleotide compounds
SG11201910191RA (en) A peptide capable of forming a gel for use in tissue engineering and bioprinting
SG11201804384UA (en) Geometric configurations for gastric residence systems
SG11201908971RA (en) Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
SG11201908790PA (en) Glucocorticoid receptor modulators to treat cervical cancer
SG11201908075UA (en) A microneedle device
SG11201901063SA (en) Therapeutic agents for neurodegenerative diseases
SG11201804443UA (en) Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndrome
SG11201806340YA (en) Zika virus vaccine
SG11201805570WA (en) Systems and methods for long term transdermal administration
SG11201907358RA (en) Intrasite administration and dosing methods and pharmaceuticals for use therein
SG11201907209QA (en) Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
SG11201810801QA (en) Brain delivery protein
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201408124PA (en) Differentiation of human embryonic stem cells into pancreatic endocrine cells
SG11201906663VA (en) Bone-targeting antibodies
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201807398UA (en) Versatile, flexible and biocompatible elastomeric microtubes
SG11201809341PA (en) Mobile robot
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201904535VA (en) Prevention and treatment of bone and cartilage damage or disease
SG11201809534UA (en) Methods of treating autoimmune disease using allogeneic t cells
SG11201906959RA (en) Aryl hydrocarbon receptor (ahr) modulator compounds
SG11201807977XA (en) Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor